Aaron Provenzano
Experienced in Anemia

Dr. Aaron Provenzano

Hematology Oncology
UPMC
Trinity Tony Teramana Medical Oncology, In Partnership With UPMC Hillman Cancer Center
3204 Johnson Road, 
Steubenville, OH 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Experienced in Anemia
UPMC
Trinity Tony Teramana Medical Oncology, In Partnership With UPMC Hillman Cancer Center
3204 Johnson Road, 
Steubenville, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Aaron P. Provenzano, DO, is a hematologist/medical oncologist and treats all types of cancers using chemotherapy, immunotherapy, and molecularly targeted therapies. He also evaluates and manages blood disorders, both benign and malignant.

Dr. Provenzano is rated as an Experienced provider by MediFind in the treatment of Anemia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Hemophilia B.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in OH
Board Certifications
American Osteopathic Board Of Internal Medicine
American Osteopathic Board Of Internal Medicine
Fellowships
West Virginia University School of Medicine
Hospital Affiliations
Wheeling Hospital, Inc
Harrison Community Hospital
East Liverpool City Hospital
Trinity Medical Ctr East &Trinity Medical Ctr West
Weirton Medical Center, Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Trinity Tony Teramana Medical Oncology, in partnership with UPMC Hillman Cancer Center
3204 Johnson Road, Steubenville, OH 43952
Call: 740-266-3900

Additional Areas of Focus

Dr. Provenzano has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Enrollment Status: Recruiting
Publish Date: December 12, 2025
Intervention Type: Drug
Study Drugs: Vismodegib, GSK2256098, Capivasertib, Abemaciclib
Study Phase: Phase 2
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Use of Response-Adapted Hypofractionated Radiation Therapy to Potentiate the Systemic Immune Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Use of Response-Adapted Hypofractionated Radiation Therapy to Potentiate the Systemic Immune Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: April 01, 2025
Intervention Type: Radiation, Drug
Study Phase: Not Applicable
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: August 02, 2024
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy
Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy
Enrollment Status: Terminated
Publish Date: April 25, 2023
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
View 6 Less Clinical Trials

1 Total Publications

Overcoming endocrine resistance in breast cancer: role of the PI3K and the mTOR pathways.
Overcoming endocrine resistance in breast cancer: role of the PI3K and the mTOR pathways.
Journal: Expert review of anticancer therapy
Published: February 15, 2013
Similar Doctors
Distinguished in Anemia
Dr. Nagaprasad N. Nagajothi
Hematology Oncology | Hematology | Oncology
Distinguished in Anemia
Dr. Nagaprasad N. Nagajothi
Hematology Oncology | Hematology | Oncology

Tri-County Hematology And Oncology Associates Inc

7337 Caritas Cir Nw, Suite 150, 
Massillon, OH 
 (53.1 miles away)
330-478-0001
Languages Spoken:
English, Hindi, Tamil, Telugu, Urdu
See accepted insurances
Accepting New Patients

Nagaprasad Nagajothi is a Hematologist Oncology specialist and a Hematologist in Massillon, Ohio. Dr. Nagajothi is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Lung Cancer, Large-Cell Immunoblastic Lymphoma, Pleuropulmonary Blastoma, and Familial Colorectal Cancer. Dr. Nagajothi is currently accepting new patients.

Distinguished in Anemia
Dr. Noman M. Rafique
Hematology Oncology | Hematology | Oncology
Distinguished in Anemia
Dr. Noman M. Rafique
Hematology Oncology | Hematology | Oncology

Tri-County Hematology And Oncology Associates Inc

7337 Caritas Cir Nw, Suite 150, 
Massillon, OH 
 (53.1 miles away)
330-478-0001
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients

Noman Rafique is a Hematologist Oncology specialist and a Hematologist in Massillon, Ohio. Dr. Rafique is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Choriocarcinoma, Familial Colorectal Cancer, Iron Deficiency Anemia, and Paget Disease of the Breast. Dr. Rafique is currently accepting new patients.

Distinguished in Anemia
Dr. Scott W. Mcgee
Hematology Oncology | Hematology | Oncology
Distinguished in Anemia
Dr. Scott W. Mcgee
Hematology Oncology | Hematology | Oncology

Tri-County Hematology And Oncology Associates Inc

7337 Caritas Cir Nw, Suite 150, 
Massillon, OH 
 (53.1 miles away)
330-478-0001
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Scott Mcgee is a Hematologist Oncology specialist and a Hematologist in Massillon, Ohio. Dr. Mcgee is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Paget Disease of the Breast, and Anemia. Dr. Mcgee is currently accepting new patients.

VIEW MORE ANEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Provenzano's expertise for a condition
ConditionClose
    • Distinguished
    • Astrocytoma
      Dr. Provenzano is
      Distinguished
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Provenzano is
      Distinguished
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    • Gliosarcoma
      Dr. Provenzano is
      Distinguished
      . Learn about Gliosarcoma.
      See more Gliosarcoma experts
    • Hemophilia B
      Dr. Provenzano is
      Distinguished
      . Learn about Hemophilia B.
      See more Hemophilia B experts
    • Lung Cancer
      Dr. Provenzano is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Neuroepithelioma
      Dr. Provenzano is
      Distinguished
      . Learn about Neuroepithelioma.
      See more Neuroepithelioma experts
    View All 9 Distinguished Conditions
    • Advanced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Provenzano is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Brain Tumor
      Dr. Provenzano is
      Advanced
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Breast Cancer
      Dr. Provenzano is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Childhood Iron Deficiency Anemia
      Dr. Provenzano is
      Advanced
      . Learn about Childhood Iron Deficiency Anemia.
      See more Childhood Iron Deficiency Anemia experts
    • EGFR Positive Lung Cancer
      Dr. Provenzano is
      Advanced
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    • Ependymoma
      Dr. Provenzano is
      Advanced
      . Learn about Ependymoma.
      See more Ependymoma experts
    View All 23 Advanced Conditions
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Provenzano is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • Acute Eosinophilic Pneumonia
      Dr. Provenzano is
      Experienced
      . Learn about Acute Eosinophilic Pneumonia.
      See more Acute Eosinophilic Pneumonia experts
    • Acute Mountain Sickness
      Dr. Provenzano is
      Experienced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Promyelocytic Leukemia
      Dr. Provenzano is
      Experienced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Adenoid Cystic Carcinoma
      Dr. Provenzano is
      Experienced
      . Learn about Adenoid Cystic Carcinoma.
      See more Adenoid Cystic Carcinoma experts
    • Adult Soft Tissue Sarcoma
      Dr. Provenzano is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    View All 106 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.